Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding

Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is ...
NewsBytes

Serum Institute to make trial Ebola vaccine using Oxford-AstraZeneca technology

The Serum Institute of India will manufacture clinical trial doses of Oxford's experimental Ebola vaccine, supported by $8.6 ...
Yahoo

‘I was desperate for the AstraZeneca vaccine to succeed. Then I became alarmed by what I saw’

Add Yahoo as a preferred source to see more of our stories on Google. Dr Sue Pavord:’It was scary. I was a mother of three kids in their 20s, and these were the people we were seeing dying’ - ...
NewsBytes

Serum Institute to manufacture Ebola vaccine developed by Oxford University

The Serum Institute of India will produce trial doses of Oxford's experimental Ebola vaccine, supported by $8.6 million in CEPI funding to combat Bundibugyo ebolavirus outbreaks.

India's Serum Institute to invest $68 million in UK vaccine maker Oxford Biomedica

Vaccine maker Serum Institute of India (SII) will invest 50 million pounds ($68 million) in Oxford Biomedica to help fund the ...

AstraZeneca admits ‘very rare’ side effect of its COVID vaccine ‘Covishield’

AZ admitted that the vaccine developed with the University of Oxford to protect against COVID-19 may cause Thrombosis with ...
Benzinga.com

AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown

European pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of Oxford, is facing a class action lawsuit alleging its vaccine caused death and serious injury in ...